新加坡报告说,有近50起疑似排气消毒病例,导致制定了新的药物条例。 Singapore reports nearly 50 suspected cases of vaping etomidate, leading to new drug regulations.

据新加坡公共卫生机构报道, 在7月9日至8月18日期间, 涉嫌吸烟埃托米达特的病例近50例, Between July 9 and August 18, Singapore's public healthcare institutions reported nearly 50 suspected cases of vaping etomidate, a drug originally used for anesthesia. 这些被称为Kpods的病例涉及混乱和头晕等症状。 These cases, known as Kpods, involve symptoms like confusion and dizziness. 截至 9 月 1 日，依托咪酯被列为 C 类管制药物，对其使用和分销实施更严格的处罚。 As of September 1, etomidate is classified as a Class C controlled drug, imposing stricter penalties for its use and distribution. 官方也在加大打击非法烟草产品的努力. Authorities are also stepping up efforts to combat illegal vape products.